학술논문
VERUBECESTAT DISEASE PROGRESSION MODELING FROM APECS, A PHASE 3 TRIAL IN PRODROMAL ALZHEIMER’S DISEASE: NO DOSE- AND EXPOSURE-DEPENDENCY IN CLINICAL ENDPOINTS
Document Type
Abstract
Author
Source
In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2019 15(7) Supplement:P249-P250
Subject
Language
ISSN
1552-5260